AAAAAA

   
Results: 1-25 |
Results: 25
MEASUREMENT OF ACTIVE COAGULATION-FACTORS IN AUTOPLEX(R)-T WITH COLORIMETRIC ACTIVE SITE-SPECIFIC ASSAY TECHNOLOGY
Authors: LUNDBLAD RL BERGSTROM J DEVREKER R BRAY G GOMPERTS E BAKER D KINGDON HS MANN KG HARTSHORN J JENNY RJ
Citation: Rl. Lundblad et al., MEASUREMENT OF ACTIVE COAGULATION-FACTORS IN AUTOPLEX(R)-T WITH COLORIMETRIC ACTIVE SITE-SPECIFIC ASSAY TECHNOLOGY, Thrombosis and haemostasis, 80(5), 1998, pp. 811-815
GENETIC RESTRICTION OF AIDS PATHOGENESIS BY AN SDF-1 CHEMOKINE GENE VARIANT
Authors: WINKLER C MODI W SMITH MW NELSON GW WU XY CARRINGTON M DEAN M HONJO T TASHIRO K YABE D BUCHBINDER S VITTINGHOFF E GOEDERT JJ OBRIEN TR JACOBSON LP DETELS R DONFIELD S WILLOUGHBY A GOMPERTS E VLAHOV D PHAIR J OBRIEN SJ
Citation: C. Winkler et al., GENETIC RESTRICTION OF AIDS PATHOGENESIS BY AN SDF-1 CHEMOKINE GENE VARIANT, Science, 279(5349), 1998, pp. 389-393
GROWTH-HORMONE SECRETION IN HIV-POSITIVE VERSUS HIV-NEGATIVE HEMOPHILIC MALES WITH ABNORMAL GROWTH AND PUBERTAL DEVELOPMENT
Authors: KAUFMAN FR GERTNER JM SLEEPER LA DONFIELD SM GOMPERTS E KAUFMAN F NELSON M PEARSON S HILGARTNER M GERTNER J GOLDBERG I HOOTS WK LOVELAND K CANTINI M WILLOUGHBY A DONFIELD S MAEDER MA CONTANT C KISKER CT STEHBENS J BALE J COOL V SIROIS P SEXAUER C HUSZTI H HAWK S ARKIN S FORSTER A SWINDELLS S RICHARD S PARMLEY R MANGOS J SCOTT A HONECK L LUSHER J WARRIER I BAIRDCOX K HERSHEY MS EYSTER ME PATTISHALL E NEAGLEY S SHAPIRO A HATCHER S DAVIGNON G RABWIN P WICKLUND B SPOOR M
Citation: Fr. Kaufman et al., GROWTH-HORMONE SECRETION IN HIV-POSITIVE VERSUS HIV-NEGATIVE HEMOPHILIC MALES WITH ABNORMAL GROWTH AND PUBERTAL DEVELOPMENT, Journal of acquired immune deficiency syndromes and human retrovirology, 15(2), 1997, pp. 137-144
IN-VIVO PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII (RECOMBINATE) USING ONE-STAGE CLOTTING AND CHROMOGENIC FACTOR-VIII ASSAY
Authors: LEE C OWENS D LILLEY P GIANGRANDE P COLLINS P HAY C BRAY G GOMPERTS E SCHROTH P BARROWSCLIFFE T
Citation: C. Lee et al., IN-VIVO PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII (RECOMBINATE) USING ONE-STAGE CLOTTING AND CHROMOGENIC FACTOR-VIII ASSAY, Blood, 90(10), 1997, pp. 143-143
PHARMACOKINETIC IN-VIVO COMPARISON USING 1-STAGE AND CHROMOGENIC SUBSTRATE ASSAYS WITH 2 FORMULATIONS OF HEMOFIL-M
Authors: LEE C BARROWCLIFFE T BRAY G GOMPERTS E HUBBARD A KEMBALLCOOK G LILLEY P OWENS D VONTILBERG L PASI J
Citation: C. Lee et al., PHARMACOKINETIC IN-VIVO COMPARISON USING 1-STAGE AND CHROMOGENIC SUBSTRATE ASSAYS WITH 2 FORMULATIONS OF HEMOFIL-M, Thrombosis and haemostasis, 76(6), 1996, pp. 950-956
GENETIC RESTRICTION OF HIV-1 INFECTION AND PROGRESSION TO AIDS BY A DELETION ALLELE OF THE CKR5 STRUCTURAL GENE
Authors: DEAN M CARRINGTON M WINKLER C HUTTLEY GA SMITH MW ALLIKMETS R GOEDERT JJ BUCHBINDER SP VITTINGHOFF E GOMPERTS E DONFIELD S VLAHOV D KASLOW R SAAH A RINALDO C DETELS R OBRIEN SJ
Citation: M. Dean et al., GENETIC RESTRICTION OF HIV-1 INFECTION AND PROGRESSION TO AIDS BY A DELETION ALLELE OF THE CKR5 STRUCTURAL GENE, Science, 273(5283), 1996, pp. 1856-1862
PROSPECTIVE, RANDOMIZED EVALUATION OF THE EFFICACY OF FIBRIN SEALANT IN NEONATES UNDERGOING ECMO
Authors: ATKINSON J GOMPERTS E BRAY G DEDRICK L KANG R LEE M
Citation: J. Atkinson et al., PROSPECTIVE, RANDOMIZED EVALUATION OF THE EFFICACY OF FIBRIN SEALANT IN NEONATES UNDERGOING ECMO, Blood, 88(10), 1996, pp. 135-135
EVIDENCE FOR A SHIFT FROM A TYPE-I LYMPHOCYTE PATTERN WITH HIV DISEASE PROGRESSION
Authors: JASON J SLEEPER LA DONFIELD SM MURPHY J WARRIER I ARKIN S EVATT B WILLOUGHBY A WASSERMAN J PEQUEGNAT W GOMPERTS E KAUFMAN F NELSON M SCHULTZE ME PEARSON S HILGARTNER M GERTNER J SCIACCA J HOOTS WK LOVELAND K CANTINI M CURRY C MCKINLAY S DONFIELD S MAEDER MA CONTANT C KISKER CT STEHBENS J BALE J COOL V ANDES WA SIROIS P SEXAUER C OLSON R BOWMAN M HAWK S ALEDORT L ARROYO M HAIRE W ERICKSON J PARMLEY R MANGOS J SCOTT A HONECK L LUSHER J BAIRDCOX K HERSHEY MS EYSTER E PATTISHALL E SCHAFER J NEAGLEY CS SHAPIRO A HATCHER S DAVIGNON G MOLLEN P WICKLUND B SPOOR M
Citation: J. Jason et al., EVIDENCE FOR A SHIFT FROM A TYPE-I LYMPHOCYTE PATTERN WITH HIV DISEASE PROGRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(4), 1995, pp. 471-476
CHARACTERIZATION OF ACTIVE COAGULANT ENZYMES IN AUTOPLEX(R)-T
Authors: BRAY GL KINGDON H LUNDBLAD R DEVREKER R GOMPERTS E BAKER D BERGSTROM J MANN K HARTSHORN J JENNY R
Citation: Gl. Bray et al., CHARACTERIZATION OF ACTIVE COAGULANT ENZYMES IN AUTOPLEX(R)-T, Blood, 86(10), 1995, pp. 766-766
SAFETY OF A SOLVENT-DETERGENT TREATED INTRAVENOUS IMMUNOGLOBULIN (GAMMAGARD(TM) S D) IN PREVIOUSLY UN-INFUSED PATIENTS/
Authors: KREUZ W SALMUN L BORTE M BRINKMAN H BRAY GL GOMPERTS E
Citation: W. Kreuz et al., SAFETY OF A SOLVENT-DETERGENT TREATED INTRAVENOUS IMMUNOGLOBULIN (GAMMAGARD(TM) S D) IN PREVIOUSLY UN-INFUSED PATIENTS/, Blood, 86(10), 1995, pp. 3419-3419
RECOMBINATE(TM) TECHNOLOGY ISSUES - PANEL DISCUSSION
Authors: MANNUCCI PM ADAMSON R INGERSLEV J KOPLOVE HM",CANDEL,"LUSHER J KISKER T DIMICHELE D CIAVARELLA N LAWRENCE J ALEDORT L GOLDSMITH JC WHITE G GOMPERTS E
Citation: Pm. Mannucci et al., RECOMBINATE(TM) TECHNOLOGY ISSUES - PANEL DISCUSSION, Annals of hematology, 68, 1994, pp. 190000025-190000028
CLINICAL ISSUES - PANEL DISCUSSION
Authors: KISKER T KASPER C WHITE G BRAY G LUSHER J MARIANI G VERMYLEN J CIAVARELLA N ALEDORT L BARROWCLIFFE T GOMPERTS E BERNTORP E GIANGRANDE P LAURIAN Y
Citation: T. Kisker et al., CLINICAL ISSUES - PANEL DISCUSSION, Annals of hematology, 68, 1994, pp. 190000039-190000043
RECOMBINATE STUDY
Authors: GOMPERTS E
Citation: E. Gomperts, RECOMBINATE STUDY, Annals of hematology, 68, 1994, pp. 190000051-190000051
VERY HIGH-PURITY FVIII ISSUES - PANEL DISCUSSION
Authors: MANNUCCI PM SCHIMPF K SEREMETIS S LUSHER J BRETTLER D WHITE G GOMPERTS E ALEDORT L CIAVARELLA N DIMICHELE D
Citation: Pm. Mannucci et al., VERY HIGH-PURITY FVIII ISSUES - PANEL DISCUSSION, Annals of hematology, 68, 1994, pp. 190000061-190000063
LONG-TERM SURVEILLANCE STUDIES - PANEL DISCUSSION
Authors: GOMPERTS E ROBERTSON J ALEDORT L DIMICHELE D BARROWCLIFFE T LUSHER J MARIANI G BERNTORP E POON MC BLANCHETTE V
Citation: E. Gomperts et al., LONG-TERM SURVEILLANCE STUDIES - PANEL DISCUSSION, Annals of hematology, 68, 1994, pp. 190000093-190000096
LONG-TERM SURVEILLANCE STUDIES - SUMMARY AND CONCLUSIONS
Authors: GOMPERTS E
Citation: E. Gomperts, LONG-TERM SURVEILLANCE STUDIES - SUMMARY AND CONCLUSIONS, Annals of hematology, 68, 1994, pp. 190000097-190000097
AIDS AND THE HUMAN GENOME PROJECT
Authors: OBRIEN SJ DEAN M WINKLER C STEPHENS JC MANN D GOEDERT J GOMPERTS E KASLOW R BUCKBINDER S
Citation: Sj. Obrien et al., AIDS AND THE HUMAN GENOME PROJECT, AIDS research and human retroviruses, 10, 1994, pp. 190000082-190000082
HEMOSTATIC EFFICACY OF FIBRIN SEALANT (HUMAN) IN HEMOPHILIACS
Authors: HOOTS K LYNES M EGGERS E BERG J MCLEOD J COURTER S GOMPERTS E
Citation: K. Hoots et al., HEMOSTATIC EFFICACY OF FIBRIN SEALANT (HUMAN) IN HEMOPHILIACS, Transfusion, 34(8), 1994, pp. 729-729
GROWTH AS A PROGNOSTIC INDICATOR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION TREATED WITH ZIDOVUDINE
Authors: MCKINNEY RE WILFERT C MODLIN JF CONNER EM MCINTOSH K BORKOWSKY W SCOTT G WEINTRUB P GOMPERTS E PIZZO PA
Citation: Re. Mckinney et al., GROWTH AS A PROGNOSTIC INDICATOR IN CHILDREN WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION TREATED WITH ZIDOVUDINE, The Journal of pediatrics, 125(5), 1994, pp. 728-733
EVIDENCE OF IN-VITRO DEVELOPMENT OF DRUG-RESISTANCE TO AZIDOTHYMIDINEIN T-LYMPHOCYTIC LEUKEMIA-CELL LINES (JURKAT E6-1 AZT-100) AND IN PEDIATRIC-PATIENTS WITH HIV-1 INFECTION/
Authors: AVRAMIS VI KWOCK R SOLORZANO MM GOMPERTS E
Citation: Vi. Avramis et al., EVIDENCE OF IN-VITRO DEVELOPMENT OF DRUG-RESISTANCE TO AZIDOTHYMIDINEIN T-LYMPHOCYTIC LEUKEMIA-CELL LINES (JURKAT E6-1 AZT-100) AND IN PEDIATRIC-PATIENTS WITH HIV-1 INFECTION/, Journal of acquired immune deficiency syndromes, 6(12), 1993, pp. 1287-1296
EPITOPE SPECIFICITY OF INHIBITOR ANTIBODIES FROM PATIENTS TREATED WITH RECOMBINANT OR PLASMA-DERIVED FACTOR-VIII
Authors: SCANDELLA D CORTER S GOMPERTS E HURST D ESMON P
Citation: D. Scandella et al., EPITOPE SPECIFICITY OF INHIBITOR ANTIBODIES FROM PATIENTS TREATED WITH RECOMBINANT OR PLASMA-DERIVED FACTOR-VIII, Thrombosis and haemostasis, 69(6), 1993, pp. 557-557
DETERMINING INHIBITOR-DEVELOPMENT RISK IN PREVIOUSLY UNTREATED HEMOPHILIA-A PATIENTS TREATED (PUPS) WITH RECOMBINANT FACTOR-VIII (RECOMBINATE(TM))
Authors: LEE ML COURTER S GOMPERTS E
Citation: Ml. Lee et al., DETERMINING INHIBITOR-DEVELOPMENT RISK IN PREVIOUSLY UNTREATED HEMOPHILIA-A PATIENTS TREATED (PUPS) WITH RECOMBINANT FACTOR-VIII (RECOMBINATE(TM)), Thrombosis and haemostasis, 69(6), 1993, pp. 856-856
SAFETY, EFFICACY AND INHIBITOR RISK OF RECOMBINANT FACTOR-VIII (RECOMBINATE(R)) IN A COHORT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH SEVERE HEMOPHILIA-A
Authors: BRAY GL COURTER S LYNES M LEE M GOMPERTS E
Citation: Gl. Bray et al., SAFETY, EFFICACY AND INHIBITOR RISK OF RECOMBINANT FACTOR-VIII (RECOMBINATE(R)) IN A COHORT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH SEVERE HEMOPHILIA-A, Thrombosis and haemostasis, 69(6), 1993, pp. 1205-1205
PILOT-STUDY TO EVALUATE EFFICACY OF FIBRIN SEALANT (HUMAN) ON HEMOSTASIS IN HEMOPHILIACS UNDERGOING TOOTH EXTRACTION
Authors: HOOTS K MCLEOD J EGGERS E BERG J LEE M GOMPERTS E
Citation: K. Hoots et al., PILOT-STUDY TO EVALUATE EFFICACY OF FIBRIN SEALANT (HUMAN) ON HEMOSTASIS IN HEMOPHILIACS UNDERGOING TOOTH EXTRACTION, Blood, 82(10), 1993, pp. 10000153-10000153
CLINICAL-STUDIES OF RECOMBINANT FACTOR-VIII (RECOMBINATE) IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA-A
Authors: BRAY GL LEE ML COURTER S GOMPERTS E
Citation: Gl. Bray et al., CLINICAL-STUDIES OF RECOMBINANT FACTOR-VIII (RECOMBINATE) IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA-A, Blood, 82(10), 1993, pp. 10000446-10000446
Risultati: 1-25 |